ABL DiagnosticsXPAR:ABLD +0.76%51 Dividend Yield % is 4.14% as of Jul. 06, 2026, which is 165% above its 10-year median of 1.56. GuruFocus rates XPAR:ABLD with a GF Score™ of 51/100 and a GF Value™ of €7.71 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 282 Healthcare Providers & Services companies, ABL Diagnostics ranks better than 78.72% on this metric.
As of today (2026-07-06), the Trailing Annual Dividend Yield of ABL Diagnostics is 4.14%.
Good Sign:
ABL Diagnostics stock Dividend Yield % is close to 1-year high.
The historical rank and industry rank for ABL Diagnostics's Dividend Yield % or its related term are showing as below:
XPAR:ABLD'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.3 Med: 1.56 Max: 4.14
Current: 4.14
During the past 13 years, the highest Dividend Yield of ABL Diagnostics was 4.14%. The lowest was 1.30%. And the median was 1.56%.
XPAR:ABLD's Dividend Yield % is ranked better than 78.72% of 282
companies
in the Healthcare Providers & Services industry
Industry Median: 2.395
vs XPAR:ABLD: 4.14
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of ABL Diagnostics is 0.82, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of ABL Diagnostics was 0.82. The lowest was 0.81. And the median was 0.81.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for ABL Diagnostics's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ABLD vs VEEV, BTSG, TEM: Dividend Yield % Comparison
For the Health Information Services subindustry, ABL Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABL Diagnostics Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ABL Diagnostics's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
ABL Diagnostics Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.110000
2026-07-03
2026-07-06
2026-07-07
Cash Dividend
annually
EUR:EUR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
ABL Diagnostics's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABL Diagnostics (XPAR:ABLD) has a Dividend Yield % of 4.14% as of Jul. 06, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on ABL Diagnostics and its competitors. This is 165% above median its historical median of 1.56. Over the past decade, ABL Diagnostics' Dividend Yield % has ranged from 1.30 to 4.14. According to the industry distribution chart, ABL Diagnostics ranks #60 out of 282 companies in the Healthcare Providers & Services industry, placing it in the top 21.3%.
Is ABL Diagnostics' Dividend Yield % too high?
ABL Diagnostics' current Dividend Yield % of 4.14% is 165% above median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 1.30 to a high of 4.14. The Healthcare Providers & Services industry median Dividend Yield % is 2.40. ABL Diagnostics' value of 4.14% is 72.9% above this industry median. Based on the distribution chart, ABL Diagnostics ranks #60 out of 282 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ABL Diagnostics has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ABL Diagnostics' Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ABL Diagnostics ranks #60 out of 282 companies for Dividend Yield %. This places ABL Diagnostics in the top 21% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.40. ABL Diagnostics' value of 4.14% is 72.9% above this benchmark. Historically, ABL Diagnostics' own Dividend Yield % has ranged from 1.30 to 4.14 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 2.40, ABL Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABL Diagnostics's current Dividend Yield % of 4.14% is 72.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on ABL Diagnostics and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABL Diagnostics's current Dividend Yield % is 4.14%, which is 165% above median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABL Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, ABL Diagnostics (XPAR:ABLD) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.71, compared to a current price of €2.66 — trading 65.5% below its estimated fair value. The current Dividend Yield % is 4.14%, which is 165% above median its 10-year median of 1.56 and 72.9% above the Healthcare Providers & Services industry median of 2.40. ABL Diagnostics' overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For ABL Diagnostics (XPAR:ABLD), the current Dividend Yield % is 4.14% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ABL Diagnostics (XPAR:ABLD) Overvalued in 2026?
Based on GuruFocus' analysis, ABL Diagnostics stock appears to be undervalued.
The current stock price of €2.66 is trading 65.5% below its estimated GF Value™ of €7.71.
GuruFocus considers ABL Diagnostics to be Significantly Undervalued.
Key valuation signals for XPAR:ABLD:
Dividend Yield %: 4.14% (165% above median its 10-year median of 1.56)
GF Value™: €7.71 vs. price of €2.66 (65.5% below fair value)
Industry Position: 72.9% above the Healthcare Providers & Services median (#60 of 282)
No single metric tells the full story. See the XPAR:ABLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
51GF Score
Get the complete analysis for XPAR:ABLD
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ABLD has been successfully added to your 
